Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 4, 2016, Pages 571-578

  Ma, W ^a   Sun, J ^a   Yang, S ^a   Zhang, L ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEFEPIME; CEPHALOSPORIN DERIVATIVE; ENEMA; EXTENDED SPECTRUM BETA LACTAMASE; GLYCOPEPTIDE; NITROIMIDAZOLE DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM ISOLATION; BLADDER CATHETERIZATION; BODY FLUID; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISK DIFFUSION; DRAINAGE TUBE; DRUG EXPOSURE; ENZYME SYNTHESIS; EPSILOMETER TEST; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; PHENOTYPIC HETERORESISTANCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; TOTAL PARENTERAL NUTRITION; URINARY CATHETER; ANTIBIOTIC RESISTANCE; BILE; BLOOD; CHINA; CLASSIFICATION; DRAINAGE; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; PATHOLOGY; RISK FACTOR; TEACHING HOSPITAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BILE; BLOOD; CASE-CONTROL STUDIES; CEPHALOSPORINS; CHINA; DRAINAGE; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETIC VARIATION; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84955595685     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2572-x     Document Type: Article

References (25)

1. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A et al (2013) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009–2010. Infect Control Hosp Epidemiol 34:1–14. doi:10.1086/668770
2. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U et al (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20(Suppl 1):1–55. doi:10.1111/1469-0691.12427
3. Tao L, Hu B, Rosenthal VD, Gao X, He L (2011) Device-associated infection rates in 398 intensive care units in shanghai, China: international nosocomial infection control consortium (INICC) findings. Int J Infect Dis 15:e774–e780. doi:10.1016/j.ijid.2011.06.009
4. Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K et al (2013) Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. medical center. Antimicrob Agents Chemother 57:4010–4018. doi:10.1128/AAC.02516-12
5. Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ (2011) Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect 44:364–368. doi:10.1016/j.jmii.2010.08.012
6. Schaumburg F, Alabi A, Kokou C, Grobusch MP, Köck R, Kaba H et al (2013) High burden of extended-spectrum β-lactamase-producing Enterobacteriaeceae in Gabon. J Antimicrob Chemother 68:2140–2143. doi:10.1093/jac/dkt164
7. Young BE, Lye DC, Krishnan P, Chan SP, Leo YS (2014) A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore. BMC Infect Dis 14:298. doi:10.1186/1471-2334-14-298
8. Kieft H, Hoepelman AI, Rozenberg-Arska M, Branger JM, Voskuil JH, Geers AB et al (1994) Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome. Antimicrob Agents Chemother 38:415–421. doi:10.1128/AAC.38.3.415
9. Mansouri M, Ramazanzadeh R, Norabadi P (2011) Cefepime resistance and associated risk factors among Escherichia coli strains isolated from clinical specimens. Chemotherapy 57:134–137. doi:10.1159/000323623
10. Shubert C, Slaughter J, Creely D, van Belkum A, Gayral JP, Dunne WM et al (2014) Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing. Antimicrob Agents Chemother 58(3):1779–1781. doi:10.1128/AAC.02181-13
11. Hung KH, Wang MC, Huang AH, Yan JJ, Wu JJ (2012) Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii. J Clin Microbiol 50:721–726. doi:10.1128/JCM.05085-11
12. Falagas ME, Makris GC, Dimopoulos G, Matthaiou DK (2008) Heteroresistance: a concern of increasing clinical significance? Clin Microbiol Infect 14:101–104. doi:10.1111/j.1469-0691.2007.01912.x
13. Zhang C, Xu X, Pu S, Huang S, Sun J, Yang S et al (2014) Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China. Infect Genet Evol 27:271–276. doi:10.1016/j.meegid.2014.07.031
14. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH et al (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
15. El-Halfawy OM, Valvano MA (2015) Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev 28:191–207. doi:10.1128/CMR.00058-14
16. Wong Ng J, Chatenay D, Robert J, Poirier MG (2010) Plasmid copy number noise in monoclonal populations of bacteria. Phys Rev E Stat Nonlinear Soft Matter Phys 81(1):011909. doi:10.1103/PhysRevE.81.011909
17. Adam M, Murali B, Glenn NO, Potter SS (2008) Epigenetic inheritance based evolution of antibiotic resistance in bacteria. BMC Evol Biol 8:52. doi:10.1186/1471-2148-8-52
18. Sun JD, Huang SF, Yang SS, Pu SL, Zhang CM, Zhang LP (2015) Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. Clin Microbiol Infect 21:469. doi:10.1016/j.cmi.2014.12.013
19. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657–686. doi:10.1128/CMR.18.4.657-686.2005
20. Walsh TR, Toleman MA, Poirel L, Nordmann P (2005) Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 18:306–325. doi:10.1128/CMR.18.2.306-325.2005
21. Wang X, Kang Y, Luo C, Zhao T, Liu L, Jiang X et al (2014) Heteroresistance at the single-cell level: adapting to antibiotic stress through a population-based strategy and growth-controlled interphenotypic coordination. MBio 5:e00942-13. doi:10.1128/mBio.00942-13
22. Fernández-Cuenca F, Gómez-Sánchez M, Rodríguez-Baño J, Martínez-Martínez L, Vila J, Bou G et al (2012) Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems. Int J Antimicrob Agents 40:235–238. doi:10.1016/j.ijantimicag.2012.05.005
23. Kudsk KA, Croce MA, Fabian TC, Minard G, Tolley EA, Poret HA et al (1992) Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 215:503–511
24. Wan X, Bi J, Gao X, Tian F, Wang X, Li N et al (2015) Partial enteral nutrition preserves elements of gut barrier function, including innate immunity, intestinal alkaline phosphatase (IAP) level, and intestinal microbiota in mice. Nutrients 7:6294–6312. doi:10.3390/nu7085288
25. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES et al (2009) A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49:682–690. doi:10.1086/604713